What question did this study set out to answer?

This research examines the effectiveness of aspirin for preventing cardiovascular events in individuals with diabetes.

May 27, 2010Diabetes CareOpen Access

Aspirin for Primary Prevention of Cardiovascular Events in People With Diabetes

View Full Paper

Ask AI

Bookmark

Why the study?

Does aspirin prevent cardiovascular events and mortality in patients with diabetes and no previous cardiovascular events?

Population

Patients with diabetes and no previous cardiovascular events (primary prevention)

Design

Review

Authors

MPMichael PignonePreventive Cardiology MAMark J. AlbertsVascular Medicine JCJohn A. ColwellThe University of Queensland

Discussion

Member takes

Implication

Guidelines advise individualized aspirin use in diabetes without prior CVD; leaves open need for updated primary prevention trials.

Key Points

This research examines the effectiveness of aspirin for preventing cardiovascular events in individuals with diabetes.
Analyzed cardiovascular risks among diabetic patients aged 45–79 years regarding aspirin therapy.
Reviewed FDA recommendations and U.S. Preventive Services Task Force guidelines on aspirin for primary prevention.
Evaluated previous recommendations by the American Diabetes Association and American Heart Association on aspirin usage.
Diabetic individuals face a significantly higher risk of cardiovascular events compared to non-diabetics.
FDA has not approved aspirin for primary prevention in individuals without prior cardiovascular events.
Task Force recommends aspirin use primarily in men and women aged 45–79, regardless of diabetes status.

Structured PICO

Does aspirin prevent cardiovascular events and mortality in patients with diabetes and no previous cardiovascular events?

Population

Patients with diabetes and no previous cardiovascular events (primary prevention)

Intervention

Aspirin (75-162 mg/day as recommended by ADA/AHA)

Outcome

Cardiovascular events and mortalityhard clinical

This paper reviews the rationale and current guideline recommendations for the use of aspirin in the primary prevention of cardiovascular events among patients with diabetes.

Cite This Study

Pignone et al. (2010) studied this question.

synapsesocial.com/papers/6a1fdbff3f3a87967f2e3a50 https://doi.org/10.2337/dc10-0555

Topics

Dual antiplatelet therapy Cardiovascular prevention

View Full Paper

Ask AI

Bookmark

Aspirin for Primary Prevention of Cardiovascular Events in People With Diabetes

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Topics

Aspirin for Primary Prevention of Cardiovascular Events in People With Diabetes

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Also Consider

Topics

Also Consider